Search
Search Results
-
Danlou Tablet Protects Against Myocardial Infarction Through Promoting eNOS-Dependent Endothelial Protection and Angiogenesis
Myocardial infarction (MI) is one of the leading causes of death worldwide. Danlou tablet (Dan) is an effective traditional Chinese medicine for...
-
Cardioprotective effects of Schisantherin A against isoproterenol-induced acute myocardial infarction through amelioration of oxidative stress and inflammation via modulation of PI3K-AKT/Nrf2/ARE and TLR4/MAPK/NF-κB pathways in rats
Background and aimsThe scientific community is concerned about cardiovascular disease mortality and morbidity, especially myocardial infarction (MI)....
-
The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes
BackgroundCardiovascular disease is the major cause of morbidity and mortality, particularly in type 2 diabetes mellitus (T2DM). Novel markers of...
-
Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction
Inflammation plays an important role in the development of heart failure (HF) after myocardial infarction (MI). Suppression of post-infarction...
-
Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation
BackgroundPoor sleep quality occurs in patients with psoriasis at rates nearly twice that of the general population. Chronic sleep impairment is an...
-
Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis
BackgroundMicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive...
-
High-intensity interval training protects the heart against acute myocardial infarction through SDF-1a, CXCR4 receptors, and c-kit levels
One of the best and most effective applied and tolerable approaches for cardioprotection is the regular exercise . In the situation of exercise...
-
Personalized diagnosis in suspected myocardial infarction
BackgroundIn suspected myocardial infarction (MI), guidelines recommend using high-sensitivity cardiac troponin (hs-cTn)-based approaches. These...
-
Cumulative incidence and risk factors of myocardial infarction during 20 years of follow-up: comparing two cohorts of middle-aged men born 30 years apart
ObjectiveTo study cumulative incidence and predictors of myocardial infarction (MI) in two random general population samples consisting of...
-
A Novel Deep Learning Approach for Forecasting Myocardial Infarction Occurrences with Time Series Patient Data
Myocardial Infarction (MI) commonly referred to as a heart attack, results from the abrupt obstruction of blood supply to a section of the heart...
-
Traditional and novel diagnostic biomarkers for acute myocardial infarction
BackgroundAcute myocardial infarction (AMI) is a leading cause of death worldwide. The first hours of acute myocardial infarction are correlated with...
-
CAV1 Protein Encapsulated in Mouse BMSC-Derived Extracellular Vesicles Alleviates Myocardial Fibrosis Following Myocardial Infarction by Blocking the TGF-β1/SMAD2/c-JUN Axis
AbstractExtracellular vesicles (EVs) derived from mouse bone marrow mesenchymal stem cells (mBMSCs) convey the CAV1 protein, influencing the...
-
Emergent Coronary Thrombectomy for Acute Myocardial Infarction Immediately Following Craniotomy with Tumor Resection
The management of perioperative acute myocardial infarction (AMI) following oncologic neurosurgery requires balancing competing risks of myocardial...
-
Multi-domain lifestyle intervention in older adults after myocardial infarction: rationale and design of the PIpELINe randomized clinical trial
BackgroundTraditional cardiac rehabilitation (CR) is effective in improving physical performance and prognosis after myocardial infarction (MI)....
-
Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction
The Japanese version of high bleeding risk (J-HBR) criteria was domestically proposed to identify patients at HBR after percutaneous coronary...
-
Contrast‑associated acute kidney injury in myocardial infarction patients undergoing elective percutaneous coronary intervention: insight from the Iodixanol-AKI Registry
Previous studies have reported a high occurrence of contrast-associated acute kidney injury (CA-AKI) in myocardial infarction (MI) patients...
-
Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry
BackgroundData on fibrinolytic therapy use for ST-segment elevation myocardial infarction (STEMI) and long-term clinical outcomes in develo**...
-
Post-traumatic stress disorder among heart disease patients: a clinical follow-up of individuals with myocardial infarction in the Tromsø Study
BackgroundMyocardial infarction is likely to be experienced as a life-threatening and potentially traumatic event. Approximately one-third of...
-
Major cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials
BackgroundThe effect of bone marrow-derived mononuclear cells (BM-MNCs) after acute myocardial infarction (AMI) on myocardial function indices such...
-
Timing of SGLT2i initiation after acute myocardial infarction
BackgroundPharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of...
